Presentation The Structural Heart Disease Summit 2018

Who Shouldnt Undergo TAVR? Can We Identify the Futile Non-responders?

Presenter: Howard C. Herrmann

June 22, 2018

REGISTER for free or LOG IN to view this content

Who Shouldn't Undergo TAVR? Can We Identify the ‘Futile' Non-responders?

Structural Heart

Presentation

The Structural Heart Disease Summit 2018

Aortic Valve

Up Next

Presentation The Structural Heart Disease Summit 2018

Submassive PE, Paradoxical Embolism, Residual DVT, and Large PFO: Thrombolysis, Filter, or Both?

Presenter: Horst Sievert

June 22, 2018

More slides +

Presentation The Structural Heart Disease Summit 2018

Early Commercial Experience Using the PORTICO Transcatheter Aortic Valve: 30-Day Outcomes in 973 Patients Enrolled in the Portico I Study (Cohort A)

Presenter: Francesco Maisano

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Program Update: The LOTUS Edge TAVR System: Design Characteristics, Clinical Data, and Future Vision

Presenter: Axel Linke

June 22, 2018

Country

slide